FDA Grants Approval for Cetrorelix Acetate Application ANDA218740
The FDA has granted approval for the ANDA218740 application for Cetrorelix Acetate submitted by Humanwell.
Asset / Drug
Drug and asset intelligence for Humanwell with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
GnRH Antagonist
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.